Adjunctive treatment in septic shock: What's next?

Area of Science:

• Critical Care Medicine
• Infectious Diseases
• Pharmacology

Background:

• Sepsis is a major global cause of mortality and long-term disability.
• Current sepsis management primarily involves anti-infective treatments and hemodynamic support.
• Existing adjunct therapies are limited to specific interventions like insulin, corticosteroids, and vasopressin in select cases.

Purpose of the Study:

• To review emerging adjunct therapies for sepsis management.
• To highlight novel approaches being investigated to improve sepsis treatment.

Main Methods:

• This is a narrative review summarizing current research on sepsis adjunct therapies.
• The review focuses on experimental and preliminary human data for novel interventions.

Main Results:

• Investigational therapies include selective beta-1 receptor antagonists and immune-boosting strategies.
• These novel approaches have shown promising results in experimental sepsis models and early human studies.

Conclusions:

• Adjunct therapies beyond standard care are under active investigation for sepsis.
• Future research may lead to revolutionary new treatments for sepsis management.